Provided by Tiger Trade Technology Pte. Ltd.

HCW Biologics Inc.

2.46
-0.0500-1.99%
Pre-market: 2.580.1241+5.04%04:49 EDT
Volume:102.23K
Turnover:249.40K
Market Cap:4.52M
PE:-0.09
High:2.53
Open:2.44
Low:2.34
Close:2.51
52wk High:36.65
52wk Low:1.50
Shares:1.84M
Float Shares:1.65M
Volume Ratio:0.13
T/O Rate:6.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-27.1846
EPS(LYR):-63.7804
ROE:-151.36%
ROA:-13.88%
PB:0.61
PE(LYR):-0.04

Loading ...

HCW Biologics Director Scott T. Garrett Acquires 7,736 Common Shares for $19,995.56

Reuters
·
Aug 01

HCW Biologics Issues 400,000 Pre-funded Warrants in $1.6 Million Private Placement

Reuters
·
Jul 29

HCW Biologics Inc. Announces Pricing of $1.6 Million Private Placement Offering

THOMSON REUTERS
·
Jul 29

HCW Biologics Seeks FDA Pre-ind Meeting for Hcw11-018b T-cell Engager Program

Reuters
·
Jul 23

HCW Biologics - Requests Type B Pre-ind Meeting with FDA for Hcw11-018b

THOMSON REUTERS
·
Jul 23

HCW Biologics Reaches Milestones for Its Proprietary Tetravalent Second-generation T-cell Engager Program on Track to Initiate Clinical Trials in First Half 2027

THOMSON REUTERS
·
Jul 23

HCW Biologics Reaches Milestones for Its Proprietary Tetravalent Second-Generation T-Cell Engager Program On Track To Initiate Clinical Trials in First Half 2027

GlobeNewswire
·
Jul 23

HCW Biologics Resolves Disputes, Clears Miramar Property Liens

TIPRANKS
·
Jul 01

HCW Biologics - Pays in Full Amounts Owed to Eirgenix Under Settlement Agreement on May 26, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 01

HCW Biologics - to Report Settlement of $2.8 Mln Disputed Accounts Payable in Q2 2026 - SEC Filing

THOMSON REUTERS
·
Jul 01

HCW Biologics - B&I Contractors Files Voluntary Dismissal with Prejudice Against HCW Biologics on June 26, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 01

HCW Biologics Says B&I Contractors Drops Florida Lien Crossclaims, Settles Dispute over USD 1.1 Million Lien

Reuters
·
Jul 01

HCW Biologics regains compliance with Nasdaq

TIPRANKS
·
Jun 30

HCW Biologics Executes 1-for-6 Reverse Stock Split

Reuters
·
Jun 30

HCW Biologics Regained Compliance with Bid Price Rule Per NASDAQ Compliance Letter

THOMSON REUTERS
·
Jun 30

HCW Biologics Regained Compliance with Bid Price Rule Per Nasdaq Compliance Letter

GlobeNewswire
·
Jun 30

Hcw Biologics Inc trading halted, news pending

TIPRANKS
·
Jun 30

HCW Biologics Effects 1-for-6 Reverse Stock Split June 30

Reuters
·
Jun 26

HCW Biologics Announces 1-for-6 Reverse Stock Split Effective on June 30, 2026

THOMSON REUTERS
·
Jun 26

HCW Biologics Reports Positive Phase 1 Alopecia Trial Data

TIPRANKS
·
Jun 16